Acadian Asset Management’s Integra LifeSciences IART Stock Holding History

Acadian Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-29,125	Closed	-$1.23M	–	1843
2022 Q3	$1.23M	Buy	29,125 +18,461	+173%	+$946K	0.01%	747
2022 Q2	$576K	Buy	+10,664	New	+$640K	﹤0.01%	934
2020 Q2	–	Sell	-2,682	Closed	-$120K	–	2275
2020 Q1	$120K	Buy	+2,682	New	+$141K	﹤0.01%	1312
2019 Q4	–	Sell	-41	Closed	-$2K	–	1979
2019 Q3	$2K	Buy	+41	New	+$2.44K	﹤0.01%	1839
2016 Q4	–	Sell	-18,094	Closed	-$746K	–	1693
2016 Q3	$746K	Buy	+18,094	New	+$758K	﹤0.01%	735

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Acadian Asset Management's IART Position: Q4 2022 in Review

Acadian Asset Management sold out of Integra LifeSciences (IART) in Q4 2022, closing a stake of 29,125 shares — an estimated $1.23M sold.

Acadian Asset Management first reported a position in IART in Q3 2016 and held it in 5 quarters. The position peaked at $1.23M in Q3 2022. 281 funds tracked by Wall St. Rank hold IART as of Q4 2022.

Acadian Asset Management reported no remaining Integra LifeSciences position as of Q4 2022 after selling out during the quarter.
Acadian Asset Management sold 29,125 Integra LifeSciences shares in Q4 2022, an estimated $1.23M.
Acadian Asset Management first reported a position in Integra LifeSciences in Q3 2016 and held it in 5 quarters.
Acadian Asset Management's Integra LifeSciences position peaked at $1.23M in Q3 2022.
281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2022.

Based on Acadian Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.